levodopa has been researched along with mdl 100907 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Bishop, C; Rice, KC; Taylor, JL; Ullrich, T; Walker, PD | 1 |
Brotchie, JM; Fox, SH; Huot, P; Johnston, TH; Winkelmolen, L | 1 |
Gourdon, JC; Huot, P; Maddaford, S; Nuara, SG | 1 |
3 other study(ies) available for levodopa and mdl 100907
Article | Year |
---|---|
Serotonin 2A receptor antagonist treatment reduces dopamine D1 receptor-mediated rotational behavior but not L-DOPA-induced abnormal involuntary movements in the unilateral dopamine-depleted rat.
Topics: Analysis of Variance; Animals; Behavior, Animal; Chromatography, High Pressure Liquid; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Dyskinesias; Fluorobenzenes; Functional Laterality; Levodopa; Male; Oxidopamine; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Rotarod Performance Test; Serotonin Antagonists; Stereotyped Behavior | 2006 |
5-HT2A receptor levels increase in MPTP-lesioned macaques treated chronically with L-DOPA.
Topics: Animals; Autoradiography; Brain; Dyskinesia, Drug-Induced; Female; Levodopa; Macaca fascicularis; MPTP Poisoning; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT2 Receptor Antagonists; Synaptic Transmission | 2012 |
Additive effects of mGluR
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Behavior, Animal; Bridged Bicyclo Compounds; Callithrix; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Indoles; Levodopa; Male; Parkinsonian Disorders; Piperazines; Psychotic Disorders; Pyridines; Receptors, Metabotropic Glutamate; Serotonin 5-HT2 Receptor Antagonists; Sulfonamides | 2021 |